Print Page     Close Window     

SEC Filings

10-K/A
BIOTIME INC filed this Form 10-K/A on 03/29/2017
Entire Document
 

S IGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Amendment No. 1 on Form 10-K/A to be signed on its behalf by the undersigned, thereunto duly authorized on the 28th day of March 2017.

 
BIOTIME, INC.
 
     
 
By:
/s/Michael D. West
 
   
Michael D. West, Ph.D.
 
   
Co-Chief Executive Officer
 
       
 
By:
/s/Aditya Mohanty
 
   
Aditya Mohanty
 
   
Co-Chief Executive Officer
 
 
 


© Copyright BioTime, Inc.